53 related articles for article (PubMed ID: 12696006)
21. Cytotoxic T-lymphocyte-associated antigen 4
Mirsharif ES; Rostamian A; Salehi M; Askari N; Ghazanfari T
Heliyon; 2024 Jan; 10(1):e23308. PubMed ID: 38116190
[TBL] [Abstract][Full Text] [Related]
22. The potential role for infections in the pathogenesis of autoimmune Addison's disease.
Hellesen A; Bratland E
Clin Exp Immunol; 2019 Jan; 195(1):52-63. PubMed ID: 30144040
[TBL] [Abstract][Full Text] [Related]
23. CTLA-4 Gene Haplotypes and the Risk of Chronic Hepatitis C Infection; a Case Control Study.
Sepahi S; Pasdar A; Gerayli S; Rostami S; Gholoobi A; Meshkat Z
Rep Biochem Mol Biol; 2017 Oct; 6(1):51-58. PubMed ID: 29090229
[TBL] [Abstract][Full Text] [Related]
24. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
Cho H; Kang H; Lee HH; Kim CW
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
[TBL] [Abstract][Full Text] [Related]
25. The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.
Niknam A; Karimi MH; Yaghobi R; Geramizadeh B; Roozbeh J; Salehipour M; Iravani M
Jundishapur J Microbiol; 2016 Aug; 9(8):e31338. PubMed ID: 27800130
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.
Rizk HH; Hamdy NM; Al-Ansari NL; El-Mesallamy HO
PLoS One; 2016; 11(4):e0153895. PubMed ID: 27100663
[TBL] [Abstract][Full Text] [Related]
27. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.
Mathew S; Abdel-Hafiz H; Raza A; Fatima K; Qadri I
World J Hepatol; 2016 Apr; 8(10):485-98. PubMed ID: 27057306
[TBL] [Abstract][Full Text] [Related]
28. Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.
Ksiaa Cheikhrouhou L; Lakhoua-Gorgi Y; Sfar I; Jendoubi-Ayed S; Aouadi H; Makhlouf M; Ayed K; Ben Abdallah T
World J Gastroenterol; 2015 Sep; 21(35):10150-8. PubMed ID: 26401079
[TBL] [Abstract][Full Text] [Related]
29. Role of viral and host factors in interferon based therapy of hepatitis C virus infection.
Imran M; Manzoor S; Ashraf J; Khalid M; Tariq M; Khaliq HM; Azam S
Virol J; 2013 Oct; 10():299. PubMed ID: 24079723
[TBL] [Abstract][Full Text] [Related]
30. Association of genetic variations in GNB1 with response to peginterferon plus ribavirin therapy for chronic hepatitis C in a Chinese population in Taiwan.
Lim YP; Tsai FJ; Liao WL; Tien N; Hung DZ; Peng CY; Wan L
BMC Gastroenterol; 2012 Nov; 12():167. PubMed ID: 23171003
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
Vidal F; López-Dupla M; Laguno M; Veloso S; Mallolas J; Murillas J; Cifuentes C; Gallart L; Auguet T; Sampériz G; Payeras A; Hernandez P; Arnedo M; Gatell JM; Richart C
PLoS One; 2012; 7(11):e47725. PubMed ID: 23133602
[TBL] [Abstract][Full Text] [Related]
32. A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.
Idris ZM; Yazdanbakhsh M; Adegnika AA; Lell B; Issifou S; Noordin R
Genet Test Mol Biomarkers; 2012 Jun; 16(6):488-92. PubMed ID: 22288822
[TBL] [Abstract][Full Text] [Related]
33. Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.
Tavis JE; Donlin MJ; Aurora R; Fan X; Di Bisceglie AM
Genome Med; 2011 Feb; 3(2):8. PubMed ID: 21345258
[TBL] [Abstract][Full Text] [Related]
34. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
[TBL] [Abstract][Full Text] [Related]
35. Evolution of interferon-based therapy for chronic hepatitis C.
Chen CH; Yu ML
Hepat Res Treat; 2010; 2010():140953. PubMed ID: 21152178
[TBL] [Abstract][Full Text] [Related]
36. PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis.
Ishizaki Y; Yukaya N; Kusuhara K; Kira R; Torisu H; Ihara K; Sakai Y; Sanefuji M; Pipo-Deveza JR; Silao CL; Sanchez BC; Lukban MB; Salonga AM; Hara T
Hum Genet; 2010 Apr; 127(4):411-9. PubMed ID: 20066438
[TBL] [Abstract][Full Text] [Related]
37. Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.
Fuller MJ; Shoukry NH; Gushima T; Bowen DG; Callendret B; Campbell KJ; Hasselschwert DL; Hughes AL; Walker CM
Hepatology; 2010 Feb; 51(2):378-87. PubMed ID: 19918975
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
Thio CL; Mosbruger TL; Kaslow RA; Karp CL; Strathdee SA; Vlahov D; O'Brien SJ; Astemborski J; Thomas DL
J Virol; 2004 Oct; 78(20):11258-62. PubMed ID: 15452244
[TBL] [Abstract][Full Text] [Related]
39. Genetics of liver disease: immunogenetics and disease pathogenesis.
Donaldson PT
Gut; 2004 Apr; 53(4):599-608. PubMed ID: 15016758
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenomics. What is relevant for the internal medicine specialist?].
Krüth P; Wehling M
Internist (Berl); 2003 Dec; 44(12):1524-30. PubMed ID: 14689195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
